Does Random Treatment Assignment Cause Harm to Research Participants?
Author Information
Author(s): Cary P. Gross, Harlan M. Krumholz, Gretchen Van Wye, Ezekiel J. Emanuel, David Wendler
Primary Institution: Yale University School of Medicine
Hypothesis
Does random treatment assignment in clinical trials negatively affect patient outcomes compared to individualized treatment?
Conclusion
Randomized treatment assignment in clinical trials does not harm research participants and shows no significant difference in outcomes compared to individualized treatment.
Supporting Evidence
- In 22 of the 25 studies, there were no significant differences in clinical outcomes between randomized and non-randomized patients.
- The majority of studies showed that random treatment assignment does not lead to worse health outcomes.
- The findings challenge the belief that individualized treatment is always superior to random assignment.
Takeaway
When patients are put into treatment groups by chance instead of by their doctors, it doesn't hurt their health. In fact, they do just as well as those who get to choose their treatment.
Methodology
A systematic review of 25 randomized controlled trials comparing outcomes of randomized participants and eligible non-participants who had access to the same treatments.
Potential Biases
Potential publication bias and differences in baseline health status between groups may affect outcomes.
Limitations
The findings may not be generalizable to all RCTs, especially those involving newer therapies not available outside research settings.
Participant Demographics
The studies included a diverse range of conditions, with a total of 17,934 eligible patients across various specialties.
Statistical Information
P-Value
p = 0.61
Confidence Interval
95% CI: 1.03, 1.39
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website